Inventor

SHUMAN STEWART

US31 patents

⚠️ This page may combine multiple inventors who share the name “SHUMAN STEWART”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHUMAN STEWART

MEMORIAL SLOAN KETTERING CANCER CENTER

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Use of MVA or MVADELTAE3L as immunotherapeutic agents against solid tumors

Vaccinia virus mutants useful for cancer immunotherapy

Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors

Vaccinia virus mutants useful for cancer immunotherapy

Recombinant poxviruses for cancer immunotherapy

SLOAN KETTERING INST CANCER

Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase

Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase

Methods and reagents for molecular cloning

Topoisomerase-based reagents and methods for molecular cloning

Topoisomerase-based ligation and cloning methods

Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase

Covalent joining of DNA to RNA by vaccinia topoisomerase and uses thereof

Pharmacological targeting of bacterial DNA ligase for treatment and prevention of bacterial infections

(unassigned)

Pharmacological targeting of mRNA cap formation

Pharmacological targeting of mRNA cap formation

Pharmacological targeting of mRNA cap formation

Pharmacological targeting of mRNA cap formation for treatment of parasitic infections

Pharmacological targeting of mRNA cap formation for treatment of parasitic infections

SHUMAN STEWART

Covalent joining of DNA strands to RNA strands catalyzed by vaccinia topoisomerase

Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase

LIFE TECHNOLOGIES CORP

Methods and reagents for molecular cloning